Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 10

1.

Multi-centre validation of the prognostic value of the haematopoietic cell transplantation- specific comorbidity index among recipient of allogeneic haematopoietic cell transplantation.

ElSawy M, Storer BE, Pulsipher MA, Maziarz RT, Bhatia S, Maris MB, Syrjala KL, Martin PJ, Maloney DG, Sandmaier BM, Storb R, Sorror ML.

Br J Haematol. 2015 Aug;170(4):574-83. doi: 10.1111/bjh.13476. Epub 2015 May 5.

2.

Some aspects of allogeneic stem cell transplantation in patients with myelodysplastic syndrome: advances and controversy.

Blau O, Blau IW.

Stem Cells Cloning. 2014 Dec 4;7:101-8. doi: 10.2147/SCCAA.S50514. eCollection 2014. Review.

3.

Pretransplant comorbidities maintain their impact on allogeneic stem cell transplantation outcome 5 years posttransplant: a retrospective study in a single german institution.

Chemnitz JM, Chakupurakal G, Bäßler M, Holtick U, Theurich S, Shimabukuro-Vornhagen A, Leitzke S, Von Bergwelt-Baildon MS, Scheid C.

ISRN Hematol. 2014 Mar 5;2014:853435. doi: 10.1155/2014/853435. eCollection 2014.

4.
5.

Hematopoietic stem cell transplantation.

Hatzimichael E, Tuthill M.

Stem Cells Cloning. 2010 Aug 26;3:105-17. doi: 10.2147/SCCAA.S6815. Review.

6.

Early lymphocyte recovery and outcomes after umbilical cord blood transplantation (UCBT) for hematologic malignancies.

Burke MJ, Vogel RI, Janardan SK, Brunstein C, Smith AR, Miller JS, Weisdorf D, Wagner JE, Verneris MR.

Biol Blood Marrow Transplant. 2011 Jun;17(6):831-40. doi: 10.1016/j.bbmt.2010.08.022. Epub 2010 Sep 8.

7.

High fludarabine exposure and relationship with treatment-related mortality after nonmyeloablative hematopoietic cell transplantation.

Long-Boyle JR, Green KG, Brunstein CG, Cao Q, Rogosheske J, Weisdorf DJ, Miller JS, Wagner JE, McGlave PB, Jacobson PA.

Bone Marrow Transplant. 2011 Jan;46(1):20-6. doi: 10.1038/bmt.2010.53. Epub 2010 Apr 12.

8.

A modified EBMT risk score and the hematopoietic cell transplantation-specific comorbidity index for pre-transplant risk assessment in adult acute lymphoblastic leukemia.

Terwey TH, Hemmati PG, Martus P, Dietz E, Vuong LG, Massenkeil G, Dörken B, Arnold R.

Haematologica. 2010 May;95(5):810-8. doi: 10.3324/haematol.2009.011809. Epub 2009 Dec 8.

9.

Validation of the hematopoietic cell transplantation-specific comorbidity index (HCT-CI) in single and multiple institutions: limitations and inferences.

Sorror ML, Storer B, Storb RF.

Biol Blood Marrow Transplant. 2009 Jun;15(6):757-8. doi: 10.1016/j.bbmt.2009.02.007. Epub 2009 Apr 11. No abstract available.

10.

Non-myeloablative allogeneic hematopoietic stem cell transplantation.

Shelburne N, Bevans M.

Semin Oncol Nurs. 2009 May;25(2):120-8. doi: 10.1016/j.soncn.2009.03.006. Review.

Items per page

Supplemental Content

Write to the Help Desk